Navelbine and neutropenia Patient Reports February 11, 2012

Navelbine Side Effects Report #5352381-2
Navelbine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 24, 2007. Male patient, 66 years of age, was diagnosed with squamous cell carcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal pain upper, necrotising colitis, neutropenia, pancytopenia. Navelbine dosage: 41.7 MG UNK IV. During the same period patient was treated with CISPLATIN, ROCEPHIN, TAHOR, CORTICOIDS, KYTRIL, SOLUPRED, ERYTHROPOIETINE. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5416620-1
Navelbine side effect was reported by a Health Professional from FRANCE on June 06, 2007. Male patient, 66 years of age, was diagnosed with squamous cell carcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: melaena, necrotising colitis, neutropenia. Navelbine dosage: 41.7 MG IV. During the same period patient was treated with CISPLATIN, ROCEPHIN, TAHOR, CORTICOIDS, KYTRIL, ERYTHROPOIETINE. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5646417-9
Navelbine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 12, 2007. Male patient, 66 years of age, was diagnosed with squamous cell carcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal pain upper, colitis, melaena, neutropenia, pancytopenia. Navelbine dosage: 41.7 MG UNK IV. During the same period patient was treated with CISPLATIN, ROCEPHIN, TAHOR, CORTICOIDS, KYTRIL, SOLUPRED, ERYTHROPOIETINE. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4622844-3
Navelbine side effect was reported by a Health Professional from on Mar 25, 2005. Male patient, 57 years of age, was diagnosed with skin cancer , renal transplant and was treated with Navelbine. After drug was administered, patient experienced the following side effects: aplasia, asthenia, chills, cough, leukopenia, neutropenia, productive cough, pyrexia. Navelbine dosage: unknown. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #5421853-4
Navelbine side effect was reported by a Consumer or non-health professional from ITALY on Aug 21, 2006. Male patient was diagnosed with prostate cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: neutropenia. Navelbine dosage: 20 MG/M2 UNK IV. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, DEXAMETHASONE, METOCLOPRAMIDE. Patient recovered.

Navelbine Side Effects Report #4692729-5
Navelbine side effect was reported by a Health Professional from on June 07, 2005. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: haematemesis, neutropenia, pyrexia, thrombocytopenia. Navelbine dosage: 30MG PER DAY. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 06/01/2005.

Navelbine Side Effects Report #5955518-7
Navelbine side effect was reported by a Consumer or non-health professional from ITALY on Nov 04, 2008. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: asthenia, dyspepsia, neutropenia, thrombocytopenia. Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN, PLASIL, FLUTICASONE PROPIONATE. Patient recovered.

Navelbine Side Effects Report #5989660-1
Navelbine side effect was reported by a Consumer or non-health professional from ITALY on Nov 19, 2008. Female patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: constipation , electrolyte imbalance, neutropenia. Navelbine dosage: 25 MG/M2 IV. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4740693-2
Navelbine side effect was reported by a Health Professional from UNITED KINGDOM on Aug 04, 2005. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer, pain , constipation , dyspepsia, diabetes mellitus and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anaemia, leukopenia, lower respiratory tract infection, neutropenia, pyrexia. Navelbine dosage: 25MGM2 CYCLIC. During the same period patient was treated with CISPLATIN, MORPHINE, LANSOPRAZOLE, GLICLAZIDE, CIPROFLOXACIN, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #6052233-9
Navelbine side effect was reported by a Consumer or non-health professional from GERMANY on Jan 07, 2009. Male patient, 63 years of age, weighting 169.8 lb, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, cardiac failure, febrile neutropenia, platelet count decreased, pleural effusion, pneumonia , sepsis , white blood cell count decreased. Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN, PACLITAXEL. Patient was hospitalized. Patient died on 10/01/2008.

Navelbine Side Effects Report #4608831-X
Navelbine side effect was reported by a Physician from on Mar 14, 2005. Male patient, 58 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anaemia, deep vein thrombosis , leukopenia, neuropathy, neutropenia, thrombophlebitis superficial. Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN, ZYLORIC, KALIUM, AMPHO. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4801689-5
Navelbine side effect was reported by a Health Professional from FRANCE on Oct 14, 2005. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: agranulocytosis, chills, diarrhoea, hypokalaemia, neutropenia, vomiting. Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5428568-7
Navelbine side effect was reported by a Physician from UNITED STATES on June 07, 2006. Female patient was diagnosed with metastatic malignant melanoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: neutropenia. Navelbine dosage: 30 MG/M2 IV. Patient recovered.

Navelbine Side Effects Report #4646710-2
Navelbine side effect was reported by a Physician from on Apr 26, 2005. Female patient was diagnosed with mesothelioma  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: acidosis, anoxia, blood creatinine increased, depressed level of consciousness, diarrhoea, hypotension, neutropenia, pyrexia, renal failure acute. Navelbine dosage: 30MG CYCLIC. Patient was hospitalized. Patient died on 04/11/2005.


Navelbine Side Effects Report #4907143-4
Navelbine side effect was reported by a Health Professional from FRANCE on Dec 20, 2005. Male patient, 58 years of age, was diagnosed with lung adenocarcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: neutropenia, pulmonary embolism , septic shock, thrombocytopenia. Navelbine dosage: unknown. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5428570-5
Navelbine side effect was reported by a Physician from UNITED STATES on May 23, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: neutropenia. Navelbine dosage: 30 MG/M2 IV. Patient recovered.

Navelbine Side Effects Report #5906775-4
Navelbine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 18, 2008. Male patient was diagnosed with burkitt's lymphoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: bone marrow failure, neutropenia, pneumonia , pneumonia bacterial, stenotrophomonas infection, thrombocytopenia. Navelbine dosage: 20 MG/M2 IV. During the same period patient was treated with GEMCITABINE, TOPOTECAN, THIOTEPA, DEXAMETHASONE, NEUPOGEN. Patient died.

Navelbine Side Effects Report #5986413-5
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Nov 17, 2008. Female patient, 70 years of age, was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: blood albumin decreased, breast cancer recurrent, condition aggravated, haematocrit decreased, leukopenia, nausea , neoplasm, neutropenia, protein total decreased. Navelbine dosage: unknown. Patient recovered.

Navelbine Side Effects Report #5851904-4
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Aug 06, 2008. Male patient, 69 years of age, was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia, upper respiratory tract inflammation. Navelbine dosage: 25 MG/M2, CYCLICAL INTRAVENOUS, 20 MG/M2, CYCLICAL INTRAVENOUS. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #5844445-1
Navelbine side effect was reported by a Health Professional from JAPAN on July 30, 2008. Male patient, 68 years of age, was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, leukopenia, platelet count decreased, platelet disorder, red blood cell count decreased, upper respiratory tract inflammation. Navelbine dosage: 25 MG/M2 ONCE IV. During the same period patient was treated with FOIPAN, HYPEN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5416675-4
Navelbine side effect was reported by a Health Professional from JAPAN on May 18, 2007. Female patient, 53 years of age, was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: jaundice , leukopenia, metastases to liver, neutropenia, pneumonia aspiration. Navelbine dosage: 22 MG/M2 IV. During the same period patient was treated with NASEA, CEFAMEZIN, FLUMARIN, MORPHINE HYDROCHLORIDE, MODACIN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5500280-5
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Sept 28, 2007. Female patient was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, cardiac failure acute, leukopenia, neutropenia, pain in extremity, protein total decreased, protein total increased. Navelbine dosage: 25 MG/M2 IV. During the same period patient was treated with ADRIAMYCIN PFS, HYSRON, LOXONIN, OXYCONTIN, TAXOL. Patient was hospitalized. Patient died on 08/23/2007.

Navelbine Side Effects Report #6012670-5
Navelbine side effect was reported by a Physician from ITALY on Dec 11, 2008. Female patient, 45 years of age, was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, clonus, confusional state, convulsion, disease recurrence, encephalitis , neutropenia, paraneoplastic syndrome, pneumonia . Navelbine dosage: 42 MG IV. During the same period patient was treated with HERCEPTIN, FENTANYL, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 03/10/2008.

Navelbine Side Effects Report #4684145-7
Navelbine side effect was reported by a Health Professional from on May 31, 2005. Female patient, 64 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal pain , asthenia, neutropenia. Navelbine dosage: 49.8MG CYCLIC. During the same period patient was treated with PANTECTA, TRANKIMAZIN, SEGURIL, IBUPROFEN. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #4694657-8
Navelbine side effect was reported by a Health Professional from on May 31, 2005. Female patient, 64 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal pain , asthenia, disease progression, neutropenia. Navelbine dosage: 49.8MG CYCLIC. During the same period patient was treated with PANTECTA, TRANKIMAZIN, SEGURIL, IBUPROFEN, AREMIS. Patient was hospitalized. Patient died on 11/08/2004.

Navelbine Side Effects Report #5281147-7
Navelbine side effect was reported by a Consumer or non-health professional from GERMANY on Mar 05, 2007. Female patient, 50 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: diplopia, eye movement disorder, hypokinesia, neutropenia, retinal ischaemia. Navelbine dosage: unknown. Patient recovered.

Navelbine Side Effects Report #5421632-8
Navelbine side effect was reported by a Consumer or non-health professional from LEBANON on Aug 25, 2006. Female patient was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: neutropenia. Navelbine dosage: 25 MG/M2 1 X WK IV. During the same period patient was treated with CAPECITABINE, DOCETAXEL. Patient recovered.

Navelbine Side Effects Report #5888806-3
Navelbine side effect was reported by a Consumer or non-health professional from SWEDEN on Sept 03, 2008. Female patient, 77 years of age, was diagnosed with adenocarcinoma, lung neoplasm malignant, metastasis and was treated with Navelbine. After drug was administered, patient experienced the following side effects: agranulocytosis, diarrhoea, fatigue, hypotension, hypoxia, neutropenia, pyrexia, sepsis , vomiting. Navelbine dosage: 10 MG/ML, CYCLICAL, INTRAVENOUS. During the same period patient was treated with PARAPLATIN, LASIX, LEVAXIN, BETAPRED. Patient was hospitalized. Patient died.

Navelbine Side Effects Report #5842935-9
Navelbine side effect was reported by a Physician from SPAIN on July 08, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: diarrhoea, metabolic acidosis, neutropenia, renal failure acute, septic shock, syncope. Navelbine dosage: 25 MG/M2; CYCLICAL. During the same period patient was treated with CAPECITABINE. Patient died.